FI934106A7 - Foereningar mot cancer - Google Patents

Foereningar mot cancer Download PDF

Info

Publication number
FI934106A7
FI934106A7 FI934106A FI934106A FI934106A7 FI 934106 A7 FI934106 A7 FI 934106A7 FI 934106 A FI934106 A FI 934106A FI 934106 A FI934106 A FI 934106A FI 934106 A7 FI934106 A7 FI 934106A7
Authority
FI
Finland
Prior art keywords
cancer organizations
organizations
cancer
Prior art date
Application number
FI934106A
Other languages
English (en)
Finnish (fi)
Other versions
FI934106A0 (fi
Inventor
Graham Michael Fraser Bisset
Ann Lesley Jackman
Duncan Ian Jodrell
Original Assignee
British Tech Group
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group, Ici Plc filed Critical British Tech Group
Publication of FI934106A0 publication Critical patent/FI934106A0/fi
Publication of FI934106A7 publication Critical patent/FI934106A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI934106A 1991-03-19 1993-09-20 Foereningar mot cancer FI934106A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919105771A GB9105771D0 (en) 1991-03-19 1991-03-19 Anti-cancer compounds
PCT/GB1992/000476 WO1992016512A1 (en) 1991-03-19 1992-03-18 Anti-cancer compounds

Publications (2)

Publication Number Publication Date
FI934106A0 FI934106A0 (fi) 1993-09-20
FI934106A7 true FI934106A7 (fi) 1993-11-18

Family

ID=10691801

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934106A FI934106A7 (fi) 1991-03-19 1993-09-20 Foereningar mot cancer

Country Status (18)

Country Link
US (1) US5444061A (cg-RX-API-DMAC10.html)
EP (1) EP0509643A1 (cg-RX-API-DMAC10.html)
JP (1) JPH06505974A (cg-RX-API-DMAC10.html)
AU (1) AU655970B2 (cg-RX-API-DMAC10.html)
CA (1) CA2106583A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ195393A3 (cg-RX-API-DMAC10.html)
FI (1) FI934106A7 (cg-RX-API-DMAC10.html)
GB (2) GB9105771D0 (cg-RX-API-DMAC10.html)
HU (1) HUT67177A (cg-RX-API-DMAC10.html)
IE (1) IE920853A1 (cg-RX-API-DMAC10.html)
IL (1) IL101281A0 (cg-RX-API-DMAC10.html)
MX (1) MX9201183A (cg-RX-API-DMAC10.html)
NO (1) NO933341L (cg-RX-API-DMAC10.html)
NZ (1) NZ242023A (cg-RX-API-DMAC10.html)
SK (1) SK100993A3 (cg-RX-API-DMAC10.html)
TW (1) TW203608B (cg-RX-API-DMAC10.html)
WO (1) WO1992016512A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA921985B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
MX9801716A (es) * 1995-08-30 1998-05-31 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US7671200B2 (en) * 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7009049B2 (en) * 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
CA2489367A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
US20030236430A1 (en) * 2002-06-21 2003-12-25 Allen David Robert Preparation of protected amino acids
WO2004009036A2 (en) 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−4−オン化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
TR201901010T4 (tr) 2007-04-11 2019-02-21 Merck & Cie 18F etiketli folatlar.
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
AR121506A1 (es) 2020-03-03 2022-06-08 Pic Therapeutics Inc Inhibidores del eif4e y sus usos
IL310924A (en) 2021-08-25 2024-04-01 Pic Therapeutics Inc Eif4e inhibitors and uses thereof
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
US5187167A (en) * 1986-03-27 1993-02-16 Imperial Chemical Industries Plc Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
DE69111891T2 (de) * 1990-05-17 1996-04-04 Smith & Nephew United Inc Elektrisch leitender und adstringierender Film sowie filmbildende Zusammensetzung zur Verwendung auf der Haut.
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives

Also Published As

Publication number Publication date
HUT67177A (en) 1995-02-28
CA2106583A1 (en) 1992-09-20
ZA921985B (en) 1993-09-20
MX9201183A (es) 1994-06-30
JPH06505974A (ja) 1994-07-07
NO933341L (no) 1993-11-18
SK100993A3 (en) 1994-08-10
NZ242023A (en) 1993-12-23
TW203608B (cg-RX-API-DMAC10.html) 1993-04-11
GB2253849A (en) 1992-09-23
GB2253849B (en) 1995-01-18
IL101281A0 (en) 1992-11-15
FI934106A0 (fi) 1993-09-20
AU655970B2 (en) 1995-01-19
CZ195393A3 (en) 1994-07-13
WO1992016512A1 (en) 1992-10-01
GB9105771D0 (en) 1991-05-01
IE920853A1 (en) 1992-09-23
EP0509643A1 (en) 1992-10-21
AU1371692A (en) 1992-10-21
US5444061A (en) 1995-08-22
HU9302636D0 (en) 1993-12-28
GB9205906D0 (en) 1992-04-29
NO933341D0 (no) 1993-09-20

Similar Documents

Publication Publication Date Title
FI934106A0 (fi) Foereningar mot cancer
FI924079L (fi) Mot frysning skyddande transportenheter
FI925699L (fi) Aetliga filmer
FI931284L (fi) Foerfarande foer foerbaettring av belaeggningars resistens mot vattenblekning
DE69229234D1 (de) Schichtstoff
FI923342L (fi) Pleuromutilinkomplex
FI920728L (fi) Fukthaerdig tunnfilmelektroluminesenspanel
FI922681L (fi) Nytt foerpacknings/behaollarsystem
FI924543L (fi) Monoklonala antikroppar mot tumoerassocierade antigener, foerfarande foerderas framstaellning och anvaendning daerav
DE69221804D1 (de) Nutenschneidgerät
FI932490L (fi) Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond
FI930976L (fi) Mot tumoer riktande foerfarande och aemne
FI934447A0 (fi) Nytt immunhaemmande aemne fraon strptomyces braegensis
FI922683L (fi) Nytt foerpacknings/behaollarsystem
NO930539D0 (no) Ils sender
FI922682L (fi) Nytt foerpacknings/behaollarsystem
FI925218A0 (fi) Distansbaoge foer isolerfoerglasningar
DE69208512D1 (de) Platten-Sägegerät
KR930008505U (ko) 절취용 접착메모지
KR930002359U (ko) 절단기
KR920020645U (ko) 인절미 절단기
KR930002100U (ko) 등 때밀이대
SE9101580D0 (sv) Cirkelhack
KR920015181U (ko) 수력원동기
SE9300871D0 (sv) Kapanordning

Legal Events

Date Code Title Description
FD Application lapsed